Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RS.

JCI Insight. 2020 Jan 16;5(1). pii: 121781. doi: 10.1172/jci.insight.121781.

2.

GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.

El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein G.

Cell Signal. 2020 Jan 11:109539. doi: 10.1016/j.cellsig.2020.109539. [Epub ahead of print]

PMID:
31935430
3.

The role of exosomal long non-coding RNAs in cancer drug resistance.

De Los Santos MC, Dragomir MP, Calin GA.

Cancer Drug Resist. 2019 Dec 19;2:1178-1192. doi: 10.20517/cdr.2019.74.

4.

Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Oncul S, Amero P, Rodriguez-Aguayo C, Calin GA, Sood AK, Lopez-Berestein G.

RNA Biol. 2019 Dec 17:1-12. doi: 10.1080/15476286.2019.1702283. [Epub ahead of print]

PMID:
31847695
5.

Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer.

Chen B, Li J, Chi D, Sahnoune I, Calin S, Girnita L, Calin GA.

Cells. 2019 Dec 14;8(12). pii: E1638. doi: 10.3390/cells8121638. Review.

6.

Therapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance.

Rezaeian AH, Khanbabaei H, Calin GA.

Cancer Res. 2020 Jan 15;80(2):139-150. doi: 10.1158/0008-5472.CAN-19-1807. Epub 2019 Nov 25. Review.

PMID:
31767626
7.

Molecular aspects of medicine - Editorial 2019.

Calin GA, Fabris L.

Mol Aspects Med. 2019 Dec;70:1-2. doi: 10.1016/j.mam.2019.11.003. Epub 2019 Nov 14. No abstract available.

PMID:
31735351
8.

Genetic Variations of Ultraconserved Elements in the Human Genome.

Habic A, Mattick JS, Calin GA, Krese R, Konc J, Kunej T.

OMICS. 2019 Nov;23(11):549-559. doi: 10.1089/omi.2019.0156.

PMID:
31689173
9.

Long Non-coding RNAs in Myeloid Malignancies.

Zimta AA, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe I.

Front Oncol. 2019 Oct 18;9:1048. doi: 10.3389/fonc.2019.01048. eCollection 2019. Review.

10.

Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.

Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler M.

Cancers (Basel). 2019 Oct 17;11(10). pii: E1580. doi: 10.3390/cancers11101580. Review.

11.

A multiscale agent-based model of ductal carcinoma in situ.

Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang Z.

IEEE Trans Biomed Eng. 2019 Oct 8. doi: 10.1109/TBME.2019.2938485. [Epub ahead of print]

PMID:
31603768
12.

Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey.

Crudden C, Song D, Cismas S, Trocmé E, Pasca S, Calin GA, Girnita A, Girnita L.

Cells. 2019 Oct 9;8(10). pii: E1223. doi: 10.3390/cells8101223. Review.

13.

Current concepts of non-coding RNA regulation of immune checkpoints in cancer.

Smolle MA, Prinz F, Calin GA, Pichler M.

Mol Aspects Med. 2019 Dec;70:117-126. doi: 10.1016/j.mam.2019.09.007. Epub 2019 Sep 30. Review.

PMID:
31582259
14.

MiR-200 family and cancer: From a meta-analysis view.

Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang H, Calin GA.

Mol Aspects Med. 2019 Dec;70:57-71. doi: 10.1016/j.mam.2019.09.005. Epub 2019 Sep 23. Review.

PMID:
31558294
15.

The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.

Li Y, Chen M, Pardini B, Dragomir MP, Lucci A, Calin GA.

J Transl Med. 2019 Sep 23;17(1):318. doi: 10.1186/s12967-019-2069-y.

16.

GLS2 is protumorigenic in breast cancers.

Dias MM, Adamoski D, Dos Reis LM, Ascenção CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMG.

Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20.

PMID:
31541193
17.

The non-coding RNome after splenectomy.

Dragomir MP, Tudor S, Okubo K, Shimizu M, Chen M, Giza DE, He WR, Ivan C, Calin GA, Vasilescu C.

J Cell Mol Med. 2019 Nov;23(11):7844-7858. doi: 10.1111/jcmm.14664. Epub 2019 Sep 8.

18.

Highlighting transcribed ultraconserved regions in human diseases.

Pereira Zambalde E, Mathias C, Rodrigues AC, de Souza Fonseca Ribeiro EM, Fiori Gradia D, Calin GA, Carvalho de Oliveira J.

Wiley Interdiscip Rev RNA. 2019 Sep 5:e1567. doi: 10.1002/wrna.1567. [Epub ahead of print] Review.

PMID:
31489780
19.

Decrypting noncoding RNA interactions, structures, and functional networks.

Fabbri M, Girnita L, Varani G, Calin GA.

Genome Res. 2019 Sep;29(9):1377-1388. doi: 10.1101/gr.247239.118. Epub 2019 Aug 21.

20.

Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.

Pardini B, Sabo AA, Birolo G, Calin GA.

Cancers (Basel). 2019 Aug 14;11(8). pii: E1170. doi: 10.3390/cancers11081170. Review.

21.

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA.

Gut. 2020 Jan;69(1):18-31. doi: 10.1136/gutjnl-2018-318070. Epub 2019 Jun 6.

22.

MicroRNA based theranostics for brain cancer: basic principles.

Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP.

J Exp Clin Cancer Res. 2019 May 29;38(1):231. doi: 10.1186/s13046-019-1180-5. Review.

23.

The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors.

Bayraktar R, Bertilaccio MTS, Calin GA.

Front Immunol. 2019 May 14;10:1053. doi: 10.3389/fimmu.2019.01053. eCollection 2019. Review.

24.

Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer.

Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY.

J Natl Cancer Inst. 2019 May 24. pii: djz097. doi: 10.1093/jnci/djz097. [Epub ahead of print]

PMID:
31124563
25.

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.

Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CS.

Clin Epigenetics. 2019 May 7;11(1):71. doi: 10.1186/s13148-019-0669-2.

26.

MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer.

Pardini B, Calin GA.

Cancers (Basel). 2019 Mar 17;11(3). pii: E378. doi: 10.3390/cancers11030378. Review.

27.

Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.

Farooqi AA, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, Calin GA.

Semin Cancer Biol. 2019 Oct;58:47-55. doi: 10.1016/j.semcancer.2019.02.003. Epub 2019 Feb 8. Review.

PMID:
30742906
28.

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.

29.

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.

Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat B.

Mol Ther Nucleic Acids. 2019 Mar 1;14:301-317. doi: 10.1016/j.omtn.2018.11.019. Epub 2018 Dec 13.

30.

CRISPR-based RNA editing: diagnostic applications and therapeutic options.

Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242. Epub 2019 Jan 21. No abstract available.

PMID:
30632384
31.

The noncoding RNA revolution-three decades and still going strong!

Calin GA.

Mol Oncol. 2019 Jan;13(1):3. doi: 10.1002/1878-0261.12418. No abstract available.

32.

The long noncoding RNA KIAA0125 is upregulated in ameloblastomas.

Diniz MG, França JA, Vilas-Boas FAS, de Souza FTA, Calin GA, Gomez RS, de Sousa SF, Gomes CC.

Pathol Res Pract. 2019 Mar;215(3):466-469. doi: 10.1016/j.prp.2018.12.030. Epub 2018 Dec 26.

PMID:
30595406
33.

Role of miRNAs in immune responses and immunotherapy in cancer.

Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA.

Genes Chromosomes Cancer. 2019 Apr;58(4):244-253. doi: 10.1002/gcc.22725. Review.

PMID:
30578699
34.

S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell Persistence.

Mitra K, Feist WN, Anfossi S, Fuentes-Mattei E, Almeida MI, Kim JJ, Calin GA, Warmflash A.

ACS Synth Biol. 2019 Jan 18;8(1):25-33. doi: 10.1021/acssynbio.8b00406. Epub 2018 Dec 21.

PMID:
30550267
35.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

36.

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.

Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G.

EBioMedicine. 2018 Dec;38:100-112. doi: 10.1016/j.ebiom.2018.11.004. Epub 2018 Nov 25.

37.

Preface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing.

Calin GA.

Genes Chromosomes Cancer. 2019 Apr;58(4):189-190. doi: 10.1002/gcc.22710. Epub 2019 Jan 7. No abstract available.

PMID:
30474323
38.

The involvement of microRNA in the pathogenesis of Richter syndrome.

Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA.

Haematologica. 2019 May;104(5):1004-1015. doi: 10.3324/haematol.2018.203828. Epub 2018 Nov 8.

39.

Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2019 Jan;38(5):765-766. doi: 10.1038/s41388-018-0560-1.

PMID:
30397238
40.

Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.

Foßelteder J, Calin GA, Pichler M.

Expert Opin Ther Targets. 2018 Dec;22(12):973-976. doi: 10.1080/14728222.2018.1541453. Epub 2018 Oct 30. No abstract available.

PMID:
30365347
41.

Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.

Van Roosbroeck K, Bayraktar R, Calin GA.

Methods Mol Biol. 2019;1881:267-276. doi: 10.1007/978-1-4939-8876-1_20.

PMID:
30350212
42.

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.

Fu X, Calin GA.

EBioMedicine. 2018 Nov;37:17-18. doi: 10.1016/j.ebiom.2018.10.032. Epub 2018 Oct 15. No abstract available.

43.

Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs.

Dragomir M, Calin GA.

Front Oncol. 2018 Sep 21;8:307. doi: 10.3389/fonc.2018.00307. eCollection 2018.

44.

CpG island hypermethylation go circular (RNA).

Dragomir MP, Calin GA.

Oncotarget. 2018 Sep 4;9(69):33052-33053. doi: 10.18632/oncotarget.26074. eCollection 2018 Sep 4. No abstract available.

45.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-6.

Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S.

Noncoding RNA. 2018 Sep 18;4(3). pii: E23. doi: 10.3390/ncrna4030023.

46.

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.

Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA.

Mol Oncol. 2018 Nov;12(11):1856-1870. doi: 10.1002/1878-0261.12384. Epub 2018 Oct 15.

47.

New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?

Manga G, Calin GA, Manuc M, Droc G, Tudor S.

Chirurgia (Bucur). 2018 Jul-Aug;113(4):464-468. doi: 10.21614/chirurgia.113.4.464.

48.

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.

Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA.

Sci Rep. 2018 Aug 30;8(1):13106. doi: 10.1038/s41598-018-30989-3.

49.

Exosomal lncRNAs as new players in cell-to-cell communication.

Dragomir M, Chen B, Calin GA.

Transl Cancer Res. 2018 Mar;7(Suppl 2):S243-S252. doi: 10.21037/tcr.2017.10.46.

50.

MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.

Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA.

Mol Aspects Med. 2019 Dec;70:3-20. doi: 10.1016/j.mam.2018.07.003. Epub 2018 Aug 18. Review.

PMID:
30102929

Supplemental Content

Loading ...
Support Center